Related Experiment Video

Updated: Oct 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud

Andrew Hill1, Manya Mirchandani2, Victoria Pilkington3

  • 1Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.

Open Forum Infectious Diseases
|January 24, 2022
PubMed

Insights

Ivermectin

Area of Science:

  • Pharmacology and Clinical Medicine
  • Infectious Diseases Research

Background:

  • Ivermectin has been investigated as a potential treatment for coronavirus disease 2019 (COVID-19).
  • Early studies suggested potential clinical benefits, but evidence quality varied significantly.
  • Concerns have arisen regarding potential fraud in some clinical trials.

Purpose of the Study:

  • To conduct a subgroup meta-analysis assessing the impact of trial quality on ivermectin's effectiveness for COVID-19.
  • To stratify results based on Cochrane Risk of Bias measures and available raw data.

Main Methods:

  • Subgroup meta-analysis was performed.
  • Stratification utilized Cochrane Risk of Bias measures.
  • Raw data analysis was incorporated where feasible.

Main Results:

  • The apparent significant effect of ivermectin on survival was predominantly linked to poor-quality studies.
  • A potentially fraudulent study reported a substantial survival improvement (RR 0.08) compared to low-risk studies (RR 0.96).

Conclusions:

  • The perceived efficacy of ivermectin in improving survival is highly dependent on the quality of the studies.
  • Rigorous quality assessments, data sharing, and mitigation of publication bias are crucial for accurate clinical treatment conclusions.
Keywords:
COVID-19SARS-CoV-2ivermectin

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.9K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-1908:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
10
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
763
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
172
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
5